 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Trevi Therapeutics Inc. (TRVI)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-05-09 Purchase | 2019-05-13 5:14 pm | Trevi Therapeutics Inc. | TRVI | MOTT DAVID M 10% Owner | 2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) | View |
| 2019-05-09 Purchase | 2019-05-13 5:14 pm | Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner | 2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) | View |
| 2019-05-09 Purchase | 2019-05-13 5:15 pm | Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner | 2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) | View |
| 2019-05-09 Purchase | 2019-05-13 5:15 pm | Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner | 2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) | View |
| 2019-05-09 Purchase | 2019-05-13 6:06 pm | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 800,000 | $10 | $8,000,000 | 6,573,000 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 8:56 pm | Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 8:56 pm | Trevi Therapeutics Inc. | TRVI | Chang Carmen 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 8:58 pm | Trevi Therapeutics Inc. | TRVI | Florence Anthony A. Jr. 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 8:59 pm | Trevi Therapeutics Inc. | TRVI | Makhzoumi Mohamad 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 9:00 pm | Trevi Therapeutics Inc. | TRVI | MAKOWER JOSHUA 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 9:01 pm | Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 9:02 pm | Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 9:03 pm | Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 9:23 pm | Trevi Therapeutics Inc. | TRVI | BASKETT FOREST 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Indirect) | View |
| 2020-04-03 Sale | 2020-04-13 9:26 pm | Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-05-09 Conversion | 2019-05-13 5:14 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | MOTT DAVID M 10% Owner | 1,938,562 | $0 | 1,938,562 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 5:14 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | MOTT DAVID M 10% Owner | 17,099,316 | $0 | 0 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 5:14 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner | 1,938,562 | $0 | 1,938,562 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 5:14 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner | 17,099,316 | $0 | 0 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 5:15 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner | 1,938,562 | $0 | 1,938,562 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 5:15 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner | 17,099,316 | $0 | 0 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 5:15 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner | 1,938,562 | $0 | 1,938,562 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 5:15 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner | 17,099,316 | $0 | 0 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 6:06 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 5,773,000 | $0 | 5,773,000 (Indirect) | View |
| 2019-05-09 Other | 2019-05-13 6:06 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 48,681 | $0 | 6,524,319 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 6:06 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 13,164,257 | $0 | 0 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 6:06 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 21,739,130 | $0 | 0 (Indirect) | View |
| 2019-05-09 Conversion | 2019-05-13 6:06 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 8,243,948 | $0 | 0 (Indirect) | View |
| 2019-05-09 Other | 2019-05-13 6:06 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 1 | $0 | 1 (Indirect) | View |
| 2019-05-09 Other | 2019-05-13 6:06 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 1 | $0 | 1 (Indirect) | View |
| 2019-06-01 Exercise | 2019-06-04 4:31 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 200,000 | $0 | 6,324,319 (Indirect) | View |
| 2019-06-01 Exercise | 2019-06-04 4:31 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 1 | $0 | 0 (Indirect) | View |
| 2019-06-03 Option Award | 2019-06-05 5:04 pm | N/A 2029-06-02 | Trevi Therapeutics Inc. | TRVI | Mazabraud Yann See Remarks | 50,000 | $0 | 50,000 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 5:07 pm | N/A 2029-06-02 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L CEO | 310,000 | $0 | 310,000 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 5:08 pm | N/A 2029-06-02 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 5:09 pm | N/A 2029-06-02 | Trevi Therapeutics Inc. | TRVI | Muscolo Frank P Controller | 15,000 | $0 | 15,000 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 5:11 pm | N/A 2029-06-02 | Trevi Therapeutics Inc. | TRVI | Seiter Christopher CFO | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 4:15 pm | N/A 2030-02-12 | Trevi Therapeutics Inc. | TRVI | Seiter Christopher CFO | 65,000 | $0 | 65,000 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 4:22 pm | N/A 2030-02-12 | Trevi Therapeutics Inc. | TRVI | Mazabraud Yann See Remarks | 70,000 | $0 | 70,000 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 4:22 pm | N/A 2030-02-12 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 4:22 pm | N/A 2030-02-12 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 4:24 pm | N/A 2030-02-12 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 23,684 | $0 | 23,684 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 4:24 pm | N/A 2030-02-12 | Trevi Therapeutics Inc. | TRVI | Brett-Smith Helena Chief Development Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 4:26 pm | N/A 2030-02-12 | Trevi Therapeutics Inc. | TRVI | Muscolo Frank P Controller | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-04-03 Exercise | 2020-04-07 4:57 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 1,500,000 | $0 | 4,824,319 (Indirect) | View |
| 2020-04-03 Other | 2020-04-07 4:57 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 564 | $0 | 4,824,883 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-07 4:57 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 1 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 8:56 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 8:56 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner | 1,500,000 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 8:56 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Chang Carmen 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 8:56 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | Chang Carmen 10% Owner | 1,500,000 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 8:58 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Florence Anthony A. Jr. 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 8:58 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | Florence Anthony A. Jr. 10% Owner | 1,500,000 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 8:59 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Makhzoumi Mohamad 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 8:59 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | Makhzoumi Mohamad 10% Owner | 1,500,000 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | MAKOWER JOSHUA 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:00 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | MAKOWER JOSHUA 10% Owner | 1,500,000 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:01 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:01 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner | 1,500,000 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:02 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:02 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner | 1,500,000 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:03 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:03 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner | 1,500,000 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:23 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | BASKETT FOREST 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:23 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | BASKETT FOREST 10% Owner | 1,500,000 | $0 | 0 (Indirect) | View |
| 2020-04-03 Exercise | 2020-04-13 9:26 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 1,500,000 | $0.001 | 5,938,562 (Direct) | View |
| 2020-04-03 Exercise | 2020-04-13 9:26 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 1,500,000 | $0 | 0 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 5:00 pm | N/A 2030-06-10 | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 14,210 | $0 | 14,210 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 5:01 pm | N/A 2030-06-10 | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 14,210 | $0 | 14,210 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 5:03 pm | N/A 2030-06-10 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 14,210 | $0 | 14,210 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 5:07 pm | N/A 2030-06-10 | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 14,210 | $0 | 14,210 (Direct) | View |
| 2020-06-29 Option Award | 2020-07-01 5:58 pm | N/A 2030-06-28 | Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director | 23,684 | $0 | 23,684 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 4:20 pm | N/A 2031-01-31 | Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:15 pm | N/A 2031-02-16 | Trevi Therapeutics Inc. | TRVI | Muscolo Frank P Controller | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:15 pm | N/A 2031-02-16 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:15 pm | N/A 2031-02-16 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L CEO | 160,000 | $0 | 160,000 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:15 pm | N/A 2031-02-16 | Trevi Therapeutics Inc. | TRVI | Seiter Christopher CFO | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-04-13 Option Award | 2021-04-15 7:04 pm | N/A 2031-04-12 | Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks | 25,000 | $0 | 25,000 (Direct) | View |